Pillstats
Rx only · Tablet, Film Coated · Oral

Lamivudine

Brands: Epivir · Lamivudine

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US21 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)68244
US makers11 labelers
Packages34
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.526$1.05$1.58$2.11Dec 2025Apr 2026Jul 2026
$1.831
Latest avg · Jul 22, 2026
+11%
Since Dec 17, 2025
11
Active US suppliers
56%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8141.6K2.4K3.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.2K
Rx · 2026 Q1
76K
Units dispensed
-22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Camber Pharmaceuticals, Inc.unknown14SUPPLYING
Apotex Corp.unknown5SUPPLYING
Aurobindo Pharma Limitedunknown3SUPPLYING
Golden State Medical Supply, Inc.unknown3SUPPLYING
Macleods Pharmaceuticals Limitedunknown2SUPPLYING
Strides Pharma Science Limitedunknown2SUPPLYING
ViiV Healthcare Companyunknown2SUPPLYING
Coupler LLCunknown1SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown0SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.